Cisatracurium Besylate Injection
Product Images NDC 0143-9397

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Cisatracurium Besylate (NDC 0143-9397). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Cisatracurium Besylate Structural Formula (Cisatracurium Besylate Injection Usp Preserved 1)

Chemical structure diagram of Cisatracurium Besylate, showing its molecular components and arrangement. The structure includes multiple aromatic rings and two quaternary ammonium groups, along with the besylate counterion represented.*

FDA Label Image

Figure 1 (Cisatracurium Besylate Injection Usp Preserved 2)

A scatter plot chart showing data points with axes labeled HR (heart rate) on the vertical axis and MAP (mean arterial pressure) on the horizontal axis. The scales range from -60% to +60% on both axes, with data points clustered near the center. The chart appears to depict percentage changes of HR and MAP.*

FDA Label Image

Figure 2 (Cisatracurium Besylate Injection Usp Preserved 3)

A scatter plot chart depicting individual data points reflecting changes in heart rate (HR) on the vertical axis and mean arterial pressure (MAP) on the horizontal axis, each axis ranging from -60% to +60%. The chart appears to show the relationship between HR and MAP changes.*

FDA Label Image

Cisatracurium Besylate Injection, Usp 20 mg Per 10 mL Preserved Container Label (Cisatracurium Besylate Injection Usp Preserved 4)

Label for Cisatracurium Besylate Injection, USP with a strength of 2 mg/mL (20 mg per 10 mL), a multiple-dose vial by Hikma Pharmaceuticals USA Inc. The label includes warnings about paralysis and respiratory arrest, storage instructions, and notes that the injection is sterile and nonpyrogenic with 0.9% benzyl alcohol as a preservative. The label also shows the product NDC 0143-9397-01 and manufacturer details.*

FDA Label Image

Cisatracurium Besylate Injection, Usp 20 mg Per 10 mL Preserved Carton Label (Cisatracurium Besylate Injection Usp Preserved 5)

Label for Cisatracurium Besylate Injection, USP, 2 mg/mL (20 mg per 10 mL), multiple-dose vials, by Hikma Pharmaceuticals USA Inc. The label includes a warning that it is a paralyzing agent for intravenous use with 0.9% benzyl alcohol as a preservative. Storage instructions and manufacturer details from Hikma Farmacêutica (Portugal) are present.*

FDA Label Image

Representative Serialization Image (Cisatracurium Besylate Injection Usp Preserved 6)

Label panel with a QR code and text fields showing GTIN (00301234567896), serial number, expiration date, and lot number placeholders. No proprietary or product-specific branding information is visible beyond these identifiers.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.